<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p43" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_43{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_43{left:341px;bottom:30px;}
#t3_43{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_43{left:377px;bottom:30px;}
#t5_43{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_43{left:540px;bottom:30px;}
#t7_43{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_43{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_43{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_43{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_43{left:285px;bottom:827px;letter-spacing:-0.24px;}
#tc_43{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_43{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_43{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_43{left:1111px;bottom:28px;letter-spacing:0.1px;}
#tg_43{left:36px;bottom:182px;}
#th_43{left:42px;bottom:176px;letter-spacing:0.1px;word-spacing:-0.04px;}
#ti_43{left:325px;bottom:176px;}
#tj_43{left:36px;bottom:165px;}
#tk_43{left:46px;bottom:159px;letter-spacing:0.13px;}
#tl_43{left:261px;bottom:159px;}
#tm_43{left:36px;bottom:148px;}
#tn_43{left:42px;bottom:142px;letter-spacing:0.12px;}
#to_43{left:45px;bottom:125px;letter-spacing:0.11px;word-spacing:0.02px;}
#tp_43{left:45px;bottom:108px;letter-spacing:0.12px;}
#tq_43{left:347px;bottom:108px;letter-spacing:0.13px;}
#tr_43{left:431px;bottom:108px;}
#ts_43{left:36px;bottom:778px;letter-spacing:0.48px;}
#tt_43{left:36px;bottom:760px;letter-spacing:0.25px;}
#tu_43{left:187px;bottom:778px;letter-spacing:0.32px;word-spacing:-0.31px;}
#tv_43{left:931px;bottom:778px;letter-spacing:0.28px;word-spacing:-0.12px;}
#tw_43{left:36px;bottom:511px;letter-spacing:-0.09px;}
#tx_43{left:36px;bottom:493px;letter-spacing:-0.1px;}
#ty_43{left:36px;bottom:474px;letter-spacing:-0.07px;}
#tz_43{left:36px;bottom:456px;letter-spacing:-0.11px;}
#t10_43{left:36px;bottom:438px;letter-spacing:-0.1px;}
#t11_43{left:187px;bottom:735px;letter-spacing:-0.1px;}
#t12_43{left:187px;bottom:716px;letter-spacing:-0.09px;}
#t13_43{left:187px;bottom:698px;letter-spacing:-0.1px;}
#t14_43{left:276px;bottom:705px;letter-spacing:-0.12px;}
#t15_43{left:187px;bottom:680px;letter-spacing:-0.1px;}
#t16_43{left:187px;bottom:661px;letter-spacing:-0.13px;}
#t17_43{left:209px;bottom:669px;}
#t18_43{left:218px;bottom:661px;letter-spacing:-0.07px;}
#t19_43{left:187px;bottom:643px;letter-spacing:-0.09px;}
#t1a_43{left:187px;bottom:625px;letter-spacing:-0.09px;}
#t1b_43{left:187px;bottom:606px;letter-spacing:-0.1px;}
#t1c_43{left:187px;bottom:568px;letter-spacing:-0.1px;}
#t1d_43{left:187px;bottom:528px;letter-spacing:-0.17px;word-spacing:0.08px;}
#t1e_43{left:187px;bottom:510px;letter-spacing:-0.08px;}
#t1f_43{left:187px;bottom:492px;letter-spacing:-0.08px;}
#t1g_43{left:187px;bottom:473px;letter-spacing:-0.09px;}
#t1h_43{left:187px;bottom:455px;letter-spacing:-0.09px;}
#t1i_43{left:187px;bottom:437px;letter-spacing:-0.1px;}
#t1j_43{left:187px;bottom:418px;letter-spacing:-0.08px;}
#t1k_43{left:187px;bottom:400px;letter-spacing:-0.1px;}
#t1l_43{left:187px;bottom:382px;letter-spacing:-0.11px;}
#t1m_43{left:236px;bottom:389px;}
#t1n_43{left:187px;bottom:339px;letter-spacing:-0.1px;}
#t1o_43{left:186px;bottom:301px;letter-spacing:-0.09px;}
#t1p_43{left:186px;bottom:282px;letter-spacing:-0.11px;}
#t1q_43{left:301px;bottom:290px;letter-spacing:-0.11px;}
#t1r_43{left:186px;bottom:250px;letter-spacing:-0.1px;}
#t1s_43{left:186px;bottom:218px;letter-spacing:-0.08px;}
#t1t_43{left:1074px;bottom:525px;letter-spacing:-0.1px;}
#t1u_43{left:1074px;bottom:506px;letter-spacing:-0.09px;}
#t1v_43{left:1074px;bottom:488px;letter-spacing:-0.08px;}
#t1w_43{left:1077px;bottom:428px;letter-spacing:-0.09px;}
#t1x_43{left:1077px;bottom:410px;letter-spacing:-0.06px;}
#t1y_43{left:1077px;bottom:391px;letter-spacing:-0.08px;}
#t1z_43{left:1077px;bottom:373px;letter-spacing:-0.09px;}
#t20_43{left:1077px;bottom:355px;letter-spacing:-0.42px;}
#t21_43{left:382px;bottom:598px;letter-spacing:-0.1px;}
#t22_43{left:382px;bottom:580px;letter-spacing:-0.09px;}
#t23_43{left:537px;bottom:588px;}
#t24_43{left:382px;bottom:401px;letter-spacing:-0.09px;}
#t25_43{left:382px;bottom:383px;letter-spacing:-0.09px;}
#t26_43{left:448px;bottom:390px;}
#t27_43{left:579px;bottom:458px;letter-spacing:-0.09px;}
#t28_43{left:579px;bottom:440px;letter-spacing:-0.09px;}
#t29_43{left:579px;bottom:421px;letter-spacing:-0.11px;}
#t2a_43{left:747px;bottom:284px;letter-spacing:-0.11px;word-spacing:-0.62px;}
#t2b_43{left:935px;bottom:284px;letter-spacing:-0.24px;}
#t2c_43{left:579px;bottom:354px;letter-spacing:-0.08px;}
#t2d_43{left:579px;bottom:336px;letter-spacing:-0.09px;}
#t2e_43{left:824px;bottom:458px;letter-spacing:-0.09px;}
#t2f_43{left:824px;bottom:440px;letter-spacing:-0.1px;}
#t2g_43{left:913px;bottom:447px;letter-spacing:-0.09px;}
#t2h_43{left:824px;bottom:421px;letter-spacing:-0.09px;}
#t2i_43{left:824px;bottom:373px;letter-spacing:-0.13px;}
#t2j_43{left:848px;bottom:380px;}
#t2k_43{left:824px;bottom:354px;letter-spacing:-0.06px;}
#t2l_43{left:824px;bottom:336px;letter-spacing:-0.1px;}
#t2m_43{left:824px;bottom:318px;letter-spacing:-0.1px;}
#t2n_43{left:913px;bottom:325px;letter-spacing:-0.12px;}
#t2o_43{left:364px;bottom:302px;letter-spacing:-0.09px;}
#t2p_43{left:364px;bottom:284px;letter-spacing:-0.09px;}
#t2q_43{left:364px;bottom:265px;letter-spacing:-0.09px;}
#t2r_43{left:364px;bottom:247px;letter-spacing:-0.11px;}
#t2s_43{left:1076px;bottom:705px;letter-spacing:-0.09px;}
#t2t_43{left:1076px;bottom:687px;letter-spacing:-0.06px;}
#t2u_43{left:1076px;bottom:668px;letter-spacing:-0.08px;}
#t2v_43{left:1076px;bottom:650px;letter-spacing:-0.09px;}
#t2w_43{left:1076px;bottom:632px;letter-spacing:-0.25px;}
#t2x_43{left:614px;bottom:182px;}
#t2y_43{left:628px;bottom:176px;letter-spacing:0.12px;word-spacing:-0.03px;}
#t2z_43{left:1138px;bottom:176px;}
#t30_43{left:614px;bottom:165px;}
#t31_43{left:625px;bottom:159px;letter-spacing:0.09px;word-spacing:0.03px;}
#t32_43{left:623px;bottom:142px;letter-spacing:0.11px;}
#t33_43{left:713px;bottom:142px;letter-spacing:0.13px;word-spacing:-0.04px;}
#t34_43{left:623px;bottom:125px;letter-spacing:0.08px;word-spacing:0.06px;}
#t35_43{left:749px;bottom:125px;}
#t36_43{left:614px;bottom:114px;}
#t37_43{left:625px;bottom:108px;letter-spacing:0.12px;}
#t38_43{left:656px;bottom:108px;letter-spacing:0.12px;}
#t39_43{left:734px;bottom:108px;letter-spacing:0.08px;word-spacing:0.05px;}
#t3a_43{left:636px;bottom:686px;letter-spacing:-0.1px;}
#t3b_43{left:636px;bottom:666px;letter-spacing:-0.09px;}
#t3c_43{left:382px;bottom:535px;letter-spacing:-0.09px;}
#t3d_43{left:382px;bottom:516px;letter-spacing:-0.09px;}
#t3e_43{left:820px;bottom:526px;letter-spacing:-0.11px;}
#t3f_43{left:920px;bottom:533px;}
#t3g_43{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_43{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_43{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_43{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_43{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_43{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_43{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_43{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_43{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s8_43{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s9_43{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sa_43{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sb_43{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sc_43{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts43" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg43Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg43" style="-webkit-user-select: none;"><object width="1210" height="935" data="43/43.svg" type="image/svg+xml" id="pdf43" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_43" class="t s0_43">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_43" class="t s1_43">® </span>
<span id="t3_43" class="t s0_43">(NCCN </span>
<span id="t4_43" class="t s1_43">® </span>
<span id="t5_43" class="t s0_43">), All rights reserved. NCCN Guidelines </span>
<span id="t6_43" class="t s1_43">® </span>
<span id="t7_43" class="t s0_43">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_43" class="t s2_43">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_43" class="t s2_43">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_43" class="t s3_43">NCCN Guidelines Version 4.2024 </span>
<span id="tb_43" class="t s3_43">Cancer of the Glottic Larynx </span>
<span id="tc_43" class="t s4_43">NCCN Guidelines Index </span>
<span id="td_43" class="t s4_43">Table of Contents </span>
<span id="te_43" class="t s4_43">Discussion </span>
<span id="tf_43" class="t s5_43">GLOT-3 </span>
<span id="tg_43" class="t s6_43">j </span>
<span id="th_43" class="t s7_43">Principles of Radiation Therapy (GLOT-A)</span><span id="ti_43" class="t s8_43">. </span>
<span id="tj_43" class="t s6_43">k </span>
<span id="tk_43" class="t s7_43">Principles of Surgery (SURG-A)</span><span id="tl_43" class="t s8_43">. </span>
<span id="tm_43" class="t s6_43">l </span>
<span id="tn_43" class="t s8_43">Adverse pathologic features: extranodal extension, positive margins, close margins, </span>
<span id="to_43" class="t s8_43">pT4 primary, pN2 or pN3 nodal disease, perineural invasion, vascular invasion, </span>
<span id="tp_43" class="t s8_43">lymphatic invasion, and subglottic extension </span><span id="tq_43" class="t s7_43">(Discussion)</span><span id="tr_43" class="t s8_43">. </span>
<span id="ts_43" class="t s5_43">CLINICAL </span>
<span id="tt_43" class="t s5_43">STAGING </span>
<span id="tu_43" class="t s5_43">TREATMENT OF PRIMARY AND NECK </span><span id="tv_43" class="t s5_43">ADJUVANT TREATMENT </span>
<span id="tw_43" class="t s9_43">T3 requiring </span>
<span id="tx_43" class="t s5_43">(amenable </span>
<span id="ty_43" class="t s5_43">to) total </span>
<span id="tz_43" class="t s5_43">laryngectomy </span>
<span id="t10_43" class="t s5_43">(N0–1) </span>
<span id="t11_43" class="t s5_43">Concurrent </span>
<span id="t12_43" class="t s5_43">systemic </span>
<span id="t13_43" class="t s5_43">therapy/RT </span>
<span id="t14_43" class="t sa_43">j,m,n </span>
<span id="t15_43" class="t s5_43">or </span>
<span id="t16_43" class="t s5_43">RT </span>
<span id="t17_43" class="t sa_43">j </span>
<span id="t18_43" class="t s5_43">if patient </span>
<span id="t19_43" class="t s5_43">not candidate </span>
<span id="t1a_43" class="t s5_43">for systemic </span>
<span id="t1b_43" class="t s5_43">therapy/RT </span>
<span id="t1c_43" class="t s5_43">or </span>
<span id="t1d_43" class="t s5_43">Surgery, including </span>
<span id="t1e_43" class="t s5_43">ipsilateral or </span>
<span id="t1f_43" class="t s5_43">bilateral neck </span>
<span id="t1g_43" class="t s5_43">dissection; </span>
<span id="t1h_43" class="t s5_43">consider </span>
<span id="t1i_43" class="t s5_43">thyroidectomy </span>
<span id="t1j_43" class="t s5_43">to clear central </span>
<span id="t1k_43" class="t s5_43">compartment </span>
<span id="t1l_43" class="t s5_43">nodes </span>
<span id="t1m_43" class="t sa_43">k </span>
<span id="t1n_43" class="t s5_43">or </span>
<span id="t1o_43" class="t s5_43">Induction </span>
<span id="t1p_43" class="t s5_43">chemotherapy </span>
<span id="t1q_43" class="t sa_43">m,o </span>
<span id="t1r_43" class="t s5_43">or </span>
<span id="t1s_43" class="t s5_43">Clinical trials </span>
<span id="t1t_43" class="t s5_43">Follow-up </span>
<span id="t1u_43" class="t sb_43">(FOLL-A, 1 </span>
<span id="t1v_43" class="t sb_43">of 2) </span>
<span id="t1w_43" class="t s5_43">Recurrent </span>
<span id="t1x_43" class="t s5_43">or </span>
<span id="t1y_43" class="t s5_43">persistent </span>
<span id="t1z_43" class="t s5_43">disease </span>
<span id="t20_43" class="t sb_43">(ADV-3) </span>
<span id="t21_43" class="t s5_43">pN0 and no adverse </span>
<span id="t22_43" class="t s5_43">pathologic features </span>
<span id="t23_43" class="t sa_43">l </span>
<span id="t24_43" class="t s5_43">Adverse pathologic </span>
<span id="t25_43" class="t s5_43">features </span>
<span id="t26_43" class="t sa_43">l </span>
<span id="t27_43" class="t s5_43">Extranodal extension </span>
<span id="t28_43" class="t s5_43">and/or positive </span>
<span id="t29_43" class="t s5_43">margin </span>
<span id="t2a_43" class="t s5_43">Response Assessment </span><span id="t2b_43" class="t sb_43">(GLOT-5) </span>
<span id="t2c_43" class="t s5_43">Other risk </span>
<span id="t2d_43" class="t s5_43">features </span>
<span id="t2e_43" class="t s5_43">Systemic </span>
<span id="t2f_43" class="t s5_43">therapy/RT </span>
<span id="t2g_43" class="t sa_43">j,m </span>
<span id="t2h_43" class="t s5_43">(category 1) </span>
<span id="t2i_43" class="t s5_43">RT </span>
<span id="t2j_43" class="t sa_43">j </span>
<span id="t2k_43" class="t s5_43">or </span>
<span id="t2l_43" class="t s5_43">Consider systemic </span>
<span id="t2m_43" class="t s5_43">therapy/RT </span>
<span id="t2n_43" class="t sa_43">j,m </span>
<span id="t2o_43" class="t s5_43">CT (with contast) or </span>
<span id="t2p_43" class="t s5_43">MRI (with and without </span>
<span id="t2q_43" class="t s5_43">contrast) of primary and </span>
<span id="t2r_43" class="t s5_43">neck </span>
<span id="t2s_43" class="t s5_43">Recurrent </span>
<span id="t2t_43" class="t s5_43">or </span>
<span id="t2u_43" class="t s5_43">persistent </span>
<span id="t2v_43" class="t s5_43">disease </span>
<span id="t2w_43" class="t sb_43">(ADV-3) </span>
<span id="t2x_43" class="t s6_43">m </span>
<span id="t2y_43" class="t s7_43">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="t2z_43" class="t s8_43">. </span>
<span id="t30_43" class="t s6_43">n </span>
<span id="t31_43" class="t s8_43">When using concurrent systemic therapy/RT, the preferred agent is cisplatin </span>
<span id="t32_43" class="t s8_43">(category 1). </span><span id="t33_43" class="t s7_43">See Principles of Systemic Therapy for Non-Nasopharyngeal </span>
<span id="t34_43" class="t s7_43">Cancers (SYST-A)</span><span id="t35_43" class="t s8_43">. </span>
<span id="t36_43" class="t s6_43">o </span>
<span id="t37_43" class="t s8_43">See </span><span id="t38_43" class="t s7_43">Discussion </span><span id="t39_43" class="t s8_43">on induction chemotherapy. </span>
<span id="t3a_43" class="t sb_43">Post Systemic Therapy/RT or RT </span>
<span id="t3b_43" class="t sb_43">Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="t3c_43" class="t s5_43">pN1 without other </span>
<span id="t3d_43" class="t s5_43">risk features </span>
<span id="t3e_43" class="t s5_43">Consider RT </span>
<span id="t3f_43" class="t sa_43">j </span>
<span id="t3g_43" class="t sc_43">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
